Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia

 Supported by from the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive, and Kidney Diseases (Grants R01-HD34242 and R01-HD34243); the National Center for Research Resources (M01-RR00048, M01-RR00080); the American Diabetes Association; Diabetes UK (RD04/0002756); Kaiser Permanente Medical Center; KK Women's and Children's Hospital; Mater Mother's Hospital; Novo Nordisk; the Myre Sim Fund of the Royal College of Physicians of Edinburgh, and the Howard and Carol Bernick Family Foundation.

 The Writing Group takes responsibility for the content of this article. Members of the HAPO Study Cooperative Research Group are listed in the appendix of: HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcomes. N Engl J Med 2008;358:1991-2002.

 Cite this article as: The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: preeclampsia. Am J Obstet Gynecol 2010;202:255.e1-7.

 The racing flag logo above indicates that this article was rushed to press for the benefit of the scientific community.

 Reprints: Boyd E. Metzger, MD, Northwestern University Feinberg School of Medicine, Endocrinology, 645 N Michigan Ave., Suite 530-22, Chicago, IL 60611.

 From the members of the Writing Group [Division of Maternal-Fetal Medicine, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Petah-Tiqva, Israel (Drs Yogev, Chen, and Hod); the Department of Obstetrics and Gynecology, Women and Infants Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, RI (Dr Coustan); the Diabetes Service, Royal Women's Hospital, Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, VIC, Australia (Dr Oats); the Department of Endocrinology and Obstetric Medicine, Mater Health Services and Mater Clinical School of Medicine, University of Queensland, Brisbane, QLD, Australia (Dr McIntyre); the Division of Endocrinology, Department of Medicine (Dr Metzger), the Department of Preventive Medicine (Drs Lowe and Dyer), and the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology (Dr Dooley), Northwestern University Feinberg School of Medicine, Chicago, IL; the Diabetes Research Group, Queen's University Belfast (Dr Trimble), the Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital (Dr McCance), and the Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, and Royal Jubilee Maternity Hospital and Queen's University Belfast (Dr Hadden), Belfast, UK; the Department of Women and Child Health, Karolinska Institute, Stockholm, Sweden (Dr Persson); and the Department of Obstetrics and Gynaecology, Chinese University of Hong Kong, Hong Kong, People's Republic of China (Dr Rogers)].

PII: S0002-9378(10)00035-9

doi:10.1016/j.ajog.2010.01.024

© 2010 Mosby, Inc. All rights reserved.